IVIG treatment in post-polio patients: Evaluation of responders

Journal of Neurology

Volumn 259, Issue 12, 2012, Pages 2571-2578

  Östlund, Gunilla ^a   Broman, Lisbet ^a   Werhagen, Lars ^a   Borg, Kristian ^a  

^a Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (Sweden)

Author keywords

Follow up; IVIG; Post polio; Responders

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGE; AGED; ARTICLE; ATROPHY; BREATHING; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; EMOTION; EMPLOYMENT; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HEALTH; ONSET AGE; PAIN; PAIN ASSESSMENT; PARESIS; PHYSICAL ACTIVITY; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SHORT FORM 36; SOCIAL STATUS; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WALKING AID;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POSTPOLIOMYELITIS SYNDROME; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872104625     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6538-y     Document Type: Article

References (25)

1. Melnick JL (1996) Current status of poliovirus infections. Clin Microbiol Rev 9:293-300
2. March of Dimes Post-polio syndrome: identifying best practice in diagnosis and care. http://www.marchofdimes.com/files/PPS report.pdf. Accessed April 30, 2010
3. Borg K (1996) Post-polio muscle dysfunction 29th ENMC workshop 14-16 October 1994, Naarden, The Netherlands. Neuromuscul Disord 6:75-80
4. Trojan DA, Cashman NR (2005) Post-poliomyelitis syndrome. Muscle Nerve 31:6-19
5. Farbu E, Gilhus NE, Barnes MP, Borg K, de Visser M, Driessen A, Howard R, Nollet F, Opara J, Stalberg E (2006) EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 13:795-801
6. Gonzaelz H, Olsson T, Borg K (2010) Management of post-polio syndrome. Lancet 9:634-642
7. Gonzalez H, Khademi M, Andersson M, Wallstrǒm E, Borg K, Olsson T (2002) Prior poliomyelitis -evidence of cytokine production in the central nervous system. J Neurol Sci 205:9-13
8. Gonzalez H, Khademi M, Andersson M, Piehl F, Wallstrǒm E, Borg K, Olsson T (2004) Prior poliomyelitis -IVIG treatment reduces proinflammatory cytokine production. J Neuroimmunol 150:139-144
9. Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA (2007) Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 14:60-65
10. Fordyce CB, Gagne D, Jalili F, Alatab S, Arnold DL, Da Costa D, Sawoszczuk S, Bodner C, Shapiro S, Collet J-P, Robinson A, Le Cruguel J-P, Lapierre Y, Bar-Or A, Trojan DA (2008) Elevated serum inflammatory markers in post-poliomyelitis syndrome. J Neurol Sci 271:80-86
11. Gonzalez H, Ottervald J, Nilsson KC, Sjǒgren N, Miliotis T, Von Bahr H, Khademi M, Eriksson B, Kjellstrǒm S, Vegvari A, Harris R, Marko-Varga G, Borg K, Nilsson J, Laurell T, Olsson T, Franzén B (2009) Identification of novel candidate protein biomarkers for the post-polio syndrome -implication for diagnosis, neurodegeneration and neuroinflammation. J Proteomics 71:670-681
12. Koopman FS, Uegaki K, Gilhus NE, Beelen A, de Visser M, Nollet F (2011) Treatment for post-polio (Review). The Cochrane Library, Issue 4
13. Gonzalez H, Stibrant-Sunnerhagen K, Sjǒberg I, Kapanoides G, Olsson T, Borg K (2006) Intravenous immunoglobulin for postpolio syndrome: a randomised controlled trial. Lancet Neurol 5:493-500
14. Kaponides G, Gonzalez H, Olsson H, Borg K (2006) Effect of intravenous immunoglobulin in patients with post-polio syndrome -an uncontrolled pilot study. J Rehabil Med 38:138-140
15. Werhagen L, Borg K (2011) Effect of intravenous immunoglobulin on pain with post-polio syndrome. J Rehabil Med 43:1038-1040
16. Sullivan M, Karlsson J, Ware JR (1995) The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 41:1349-1358
17. Sullivan M, Karlsson J (1998) The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 51:1105-1113
18. Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF36 Health Survey Manual and Interpretation Guide. New England Medical Center, The Health Institute, Boston
19. Washburn, McAuley, Katula, Mihalko, Boileau (1999) PASE. Physical activity scale for the elderly. Administration and scoring instruction manual 1991. New England Research Institute, Watertown
20. Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA (1999) The physical activity for the elderly (PASE): evidence for validity. J Clin Epidemiol 52:643-651
21. PASE. Physical activity scale for the elderly (1991) Administration and scoring instruction manual. New England Research Institute, Watertown
22. Huskisson EC (1974) Measurement of pain. Lancet 2:1127-1131
23. Joyce CR, Zutshi DW (1975) Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur J Clin Pharmacol 8:415-420
24. Jensen MP, Alschuler KN, Smith AE, Verrall AM, Goetz MC, Molton IR (2011) Pain and fatigue in persons with postpolio syndrome: independent effects on functioning. ArchPhys Med Rehabil 92:1796-1801
25. Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advantages and current thought. Annu Rev Psychol 59:565-590